A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

John F.R. Robertson, Zefei Jiang, Angelo Di Leo, Shinji Ohno, Kathleen I. Pritchard, Matthew Ellis, Ian Bradbury, Christine Campbell

科研成果: 期刊稿件 › 文章 › 同行评审

6 引用 （Scopus）

指纹

探究 'A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases